Karuna Therapeutics Inc (DELISTED) (KRTX:DL)
329.83
0.00 (0.00%)
USD |
NASDAQ |
Mar 18, 16:00
Karuna Therapeutics Cash from Investing (TTM): -160.32M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -160.32M |
| September 30, 2023 | -559.38M |
| June 30, 2023 | -879.71M |
| March 31, 2023 | -631.68M |
| December 31, 2022 | -586.40M |
| September 30, 2022 | -321.80M |
| June 30, 2022 | -80.15M |
| March 31, 2022 | -55.99M |
| December 31, 2021 | -22.69M |
| September 30, 2021 | 48.99M |
| June 30, 2021 | 32.53M |
| Date | Value |
|---|---|
| March 31, 2021 | -28.13M |
| December 31, 2020 | -89.65M |
| September 30, 2020 | -191.93M |
| June 30, 2020 | -167.28M |
| March 31, 2020 | -189.74M |
| December 31, 2019 | -174.34M |
| September 30, 2019 | -106.83M |
| June 30, 2019 | -64.65M |
| March 31, 2019 | -0.132M |
| December 31, 2018 | -5.115M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-879.71M
Minimum
Jun 2023
48.99M
Maximum
Sep 2021
-222.59M
Average
-160.32M
Median
Dec 2023
Cash from Investing (TTM) Benchmarks
| Bristol-Myers Squibb Co | -21.70B |
| RayzeBio inc (DELISTED) | -- |
| Icosavax Inc (DELISTED) | -8.918M |
| Madrigal Pharmaceuticals Inc | -502.52M |
| Theseus Pharmaceuticals Inc (DELISTED) | -68.76M |